- Home
- ICMB vs INCR Comparison
ICMB vs INCR Comparison
Compare ICMB & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ICMB | INCR |
|---|---|---|
| Founded | 2012 | 1994 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.2M | 50.4M |
| IPO Year | 2013 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ICMB | INCR |
|---|---|---|
| Price | $2.91 | $0.85 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 36.4K | ★ 45.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 17.81% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $69.54 |
| Revenue Next Year | $4.75 | $41.75 |
| P/E Ratio | $73.00 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.46 | $0.68 |
| 52 Week High | $3.38 | $1.77 |
Technical Indicators
Market Signals| Indicator | ICMB | INCR |
|---|---|---|
| Relative Strength Index (RSI) | 42.94 | 43.37 |
| Support Level | $2.75 | $0.76 |
| Resistance Level | $2.90 | $0.98 |
| Average True Range (ATR) | 0.09 | 0.05 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 0.00 | 63.90 |
Price Performance
Historical ComparisonAbout ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.